CSL112 (Apolipoprotein A‐I [Human]) Reduces the Elevation in Neutrophil‐to‐Lymphocyte Ratio Induced by Acute Myocardial Infarction
Author:
Affiliation:
1. CSL Ltd Bio21 Institute Melbourne Victoria Australia
2. CSL Behring King of Prussia PA USA
3. PERFUSE Study Group Boston and Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference5 articles.
1. Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design
2. Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?
3. The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials
4. The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
5. Regulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-inflammatory mechanism of Apolipoprotein A-I;Frontiers in Immunology;2024-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3